Michael Kratsios, U.S. chief technology officer and a 2020 Wash100 Award winner, said government officials should analyze the trade-offs as they push the adoption of artificial intelligence and other emerging technologies, Nextgov reported Tuesday.
“So, think about the [Food and Drug Administration] approving an AI medical diagnostic, or think about [the Federal Aviation Administration] approving a drone—and what they should be considering in their regulatory approach,” Kratsios said Tuesday during a fireside chat in Pittsburgh.
He cited the need for agencies to perform cost-benefit analysis with regard to AI.
“I think one of the core underpinnings of the way that the White House is directing agencies to think about this is to do that actual cost-benefit analysis,” Kratsios said. “The same cost-benefit analysis that is required by statute for any other regulation should also be done in the context of AI.”
The Office of Management and Budget (OMB) released a draft of guidance in January 2020 for federal agencies as they develop regulations and policies related to AI technology. Kratsios said the guidelines would provide agencies clarity on how to look at the benefits of those technologies and assess them against some of the potential risks to come up with regulatory measures to facilitate the delivery of such platforms to the public.